NCT07447830 The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Study
| NCT ID | NCT07447830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University |
| Condition | Wound Care |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-11-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test whether immersive virtual reality (iVR) can reduce pain and discomfort during wound care for residents living in long-term care (LTC). Pressure ulcers are common and painful among older adults, and dressing changes often cause additional distress. Up to 20 residents at the Donald Berman Maimonides Geriatric Centre will use virtual reality headsets during routine wound care. The headsets display calm, low-stimulus scenes (e.g., puppies in a meadow) designed to distract and comfort participants. Each participant will take part for six weeks in three phases: * Two weeks of usual wound care (baseline) * Two weeks using virtual reality during wound care (intervention) * Two weeks of usual care again (washout) Pain will be assessed using validated tools, and the research team will also observe agitation, mood, and other behavioral indicators. Nursing staff will provide feedback on feasibility and acceptability of iVR use in LTC settings.
Eligibility Criteria
Inclusion Criteria: * Resident of LTC for ≥2 weeks * Receiving regular wound care for pressure ulcers * Able to tolerate iVR headset use * (If cognitively apt) able to understand English or French Exclusion Criteria: * Blindness, severe cataracts, or glaucoma * Allergies to synthetic plastics or headset materials * Head or ear wounds preventing headset placement * Peripheral neuropathy * Dangerous or aggressive behaviors in the past 30 days
Contact & Investigator
Machelle Wilchesky, PhD
PRINCIPAL INVESTIGATOR
Lady Davis Institute-CIUSSS du Centre-Ouest-de-l'Île-de-Montréal
Frequently Asked Questions
Who can join the NCT07447830 clinical trial?
This trial is open to participants of all sexes, studying Wound Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07447830 currently recruiting?
Yes, NCT07447830 is actively recruiting participants. Contact the research team at machelle.wilchesky@mcgill.ca for enrollment information.
Where is the NCT07447830 trial being conducted?
This trial is being conducted at Montreal, Canada, Montreal, Canada.
Who is sponsoring the NCT07447830 clinical trial?
NCT07447830 is sponsored by McGill University. The principal investigator is Machelle Wilchesky, PhD at Lady Davis Institute-CIUSSS du Centre-Ouest-de-l'Île-de-Montréal. The trial plans to enroll 25 participants.